NCT06139276

Brief Summary

The aim is to investigate whether adding small needle-knife therapy to standard Western medicine enhances the treatment of frozen shoulder by evaluating its impact on microcirculation and meridian unblocking.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2024

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 14, 2023

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 18, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

November 18, 2023

Status Verified

November 1, 2023

Enrollment Period

1 year

First QC Date

November 14, 2023

Last Update Submit

November 17, 2023

Conditions

Keywords

Frozen ShoulderAcupotomySmall Needle-KnifeAdhesive CapsulitisLaser Doppler FlowmetryPhotoplethysmographyBlood Pressure Waveform

Outcome Measures

Primary Outcomes (2)

  • Pain VAS

    The intensity of the pain along a continuum from 'no pain' to 'worst pain' imaginable with visual analog scale.

    90 days

  • ROM

    Glenohumeral range of motion(ROM) of the affected shoulder.

    90 days

Secondary Outcomes (5)

  • WHOQOL-BREF

    90 days

  • SPADI

    90 days

  • LDF

    90 days

  • BPW

    90 days

  • PPG

    90 days

Study Arms (2)

Small Needle-Knife

EXPERIMENTAL

The small needle-knife (SNF) group undergoes rehabilitation treatment, with additional small needle-knife treatment once a week after acupuncture needle insertion at the Tiaokou (ST38) and Chengshan (BL57) acupoints. This treatment regimen will span over a duration of 3 weeks.

Procedure: Small Needle-Knife

Standard treatment

ACTIVE COMPARATOR

Rehabilitation treatment (based on the physician's assessment of the patient's clinical condition, using methods such as heat therapy, electrotherapy, manual therapy, or joint injections) at least once a week. This treatment regimen will span over a duration of 3 weeks.

Other: Standard treatment

Interventions

The small needle-knife therapy originated from the ancient Chinese acupuncture instrument known as the "Pi needle" from the "Nine Needles," which resembled a sword, had two sharp edges, and was originally used for abscess drainage. It is currently widely applied in treating conditions such as myofascial adhesions, chronic pain, or nerve compression. The small needle-knife features a flat and rounded tip design, with its handle made of solid steel. This construction provides excellent toughness and flexibility, minimizing tissue damage, and facilitating microadhesiolysis, an intervention aimed at releasing adhesions.

Also known as: Acupotomy
Small Needle-Knife

Standard treatment

Standard treatment

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Limited shoulder joint mobility in various angles (forward flexion, abduction, external rotation, and internal rotation), persisting for over two months.
  • Persistent pain on the affected shoulder even without rest.
  • Willing and consenting to participate in this research.

You may not qualify if:

  • Degenerative shoulder joint arthritis (osteoarthritis).
  • Rheumatoid arthritis.
  • Fracture of the humerus, clavicle, scapula, shoulder acromioclavicular dislocation, shoulder dislocation.
  • Cervical radiculopathy.
  • Thoracic outlet syndrome.
  • Restricted shoulder joint mobility due to stroke, spinal cord injury, or other factors.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Bursitis

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Ming Jen Wang, MD

    Taipei City Hospital, Renai Branch, Chinese Medicine Department

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ming Jen Wang, MD

CONTACT

Chao Zong Chen, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study plans to collect 120 individuals diagnosed with frozen shoulder by both Western and Traditional Chinese medicine practitioners, randomized in a 1:1 ratio to receive either standard treatment or a combination of small needle-knife therapy and standard treatment.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 14, 2023

First Posted

November 18, 2023

Study Start

January 1, 2024

Primary Completion

December 31, 2024

Study Completion

December 31, 2025

Last Updated

November 18, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share